Biotech

All Articles

Galapagos pauses CAR-T tissue treatment litigation over Parkinsonism scenario

.Galapagos has paused application in a trial of a BCMA-directed CAR-T tissue treatment, pumping the ...

James Wilson leaving behind Penn to introduce 2 brand new biotechs

.After greater than thirty years, gene therapy trailblazer James Wilson M.D., Ph.D., is leaving the ...

3 biotechs try to beat the summer heat through dropping team

.As biotechs attempt to switch a new webpage in August, at the very least 3 providers have actually ...

venBio raises $528M for 5th lifestyle scientific researches VC fund

.Pro equity capital organization venBio has actually raised one more half a billion bucks to invest ...

Otsuka pays for $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Drug has gotten Boston-based Jnana Rehabs for $800 thousand so the Japanese biotech can easi...

FibroGen gives up 75% people personnel as asset fails 2 additional trials

.FibroGen is actually radically reorganizing its own business, giving up 75% of its own U.S. workers...

Tracon relax weeks after injectable PD-L1 inhibitor neglect

.Tracon Pharmaceuticals has actually made a decision to wane operations weeks after an injectable im...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 thousand in biobucks that a bispecific antibody-drug c...

Takeda takes $140M loss on failed epilepsy medication, touts FDA manage

.Our team currently recognize that Takeda is hoping to discover a path to the FDA for epilepsy medic...

VBI Injections apply for insolvency, looks for asset purchase

.Immunology biotech VBI Vaccines is actually turning dangerously close to the climax, along with pro...